IL1B and ulcer disease: A direct comparison between the ulcer + OMP and ulcer + OMP-NS groups revealed that the OMP-NS formulation significantly decreased levels of HMGB1, NLRP3, NF-κB, TLR-2, MyD88, IL-1β, IL-6, and TNF-α (Figure 11).